Browse our anti-SEMA4D (SEMA4D) Antibodies

Full name:
anti-Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4D Antibodies (SEMA4D)
On www.antibodies-online.com are 249 Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4D (SEMA4D) Antibodies from 24 different suppliers available. Additionally we are shipping SEMA4D Proteins (30) and SEMA4D Kits (23) and many more products for this protein. A total of 311 SEMA4D products are currently listed.
Synonyms:
C9orf164, CD100, COLL-4, M-sema-G, Semacl2, Semaj, Semcl2
list all antibodies Gene Name GeneID UniProt
SEMA4D 306790  
SEMA4D 10507 Q92854
SEMA4D 20354 O09126

Show all species

Show all synonyms

Most Popular Reactivities for anti-SEMA4D (SEMA4D) Antibodies

Select your species and application

anti-Rat (Rattus) SEMA4D Antibodies:

anti-Human SEMA4D Antibodies:

anti-Mouse (Murine) SEMA4D Antibodies:

All available anti-SEMA4D Antibodies

Go to our pre-filtered search.

Top referenced anti-SEMA4D Antibodies

  1. Mouse (Murine) Monoclonal SEMA4D Primary Antibody for FACS - ABIN1449183 : Maas, Chan, Parker, Slater, Moore, Olsen, Aune: Cutting edge: molecular portrait of human autoimmune disease. in Journal of immunology (Baltimore, Md. : 1950) 2002 (PubMed)
    Show all 5 references for 1449183

  2. Human Monoclonal SEMA4D Primary Antibody for FACS, ICFC - ABIN2661450 : Bougeret, Mansur, Dastot, Schmid, Mahouy, Bensussan, Boumsell: Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. in Journal of immunology (Baltimore, Md. : 1950) 1992 (PubMed)
    Show all 4 references for 2661450

  3. Human Monoclonal SEMA4D Primary Antibody for FACS - ABIN319838 : Yoshino, Ami, Terao, Tashiro, Honda: Upgrading of flow cytometric analysis for absolute counts, cytokines and other antigenic molecules of cynomolgus monkeys (Macaca fascicularis) by using anti-human cross-reactive antibodies. in Experimental animals / Japanese Association for Laboratory Animal Science 2000 (PubMed)
    Show all 3 references for 319838

  4. Mouse (Murine) Monoclonal SEMA4D Primary Antibody for FACS - ABIN2853598 : Moreau-Fauvarque, Kumanogoh, Camand, Jaillard, Barbin, Boquet, Love, Jones, Kikutani, Lubetzki, Dusart, Chédotal: The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2003 (PubMed)
    Show all 2 references for 2853598

  5. Human Monoclonal SEMA4D Primary Antibody for FACS, IP - ABIN319841 : Aversa, Waugh, Bishop, Hall: Use of monoclonal antibodies to study in vivo and in vitro-activated lymphocytes. in Transplantation proceedings 1989 (PubMed)

  6. Human Monoclonal SEMA4D Primary Antibody for IF, IP - ABIN968101 : Hall, Boumsell, Schultze, Boussiotis, Dorfman, Cardoso, Bensussan, Nadler, Freeman: Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. in Proceedings of the National Academy of Sciences of the United States of America 1996 (PubMed)

  7. Human Monoclonal SEMA4D Primary Antibody for FACS - ABIN4896535 : He, Guo, Zhou, Zhang, Fan, Ji, Wang, Ma, Lian, Hao, Yao, Jia: CD100 up-regulation induced by interferon-α on B cells is related to hepatitis C virus infection. in PLoS ONE 2014 (PubMed)

More Antibodies against SEMA4D Interaction Partners

Human Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4D (SEMA4D) interaction partners

  1. We identified a novel genome-wide significant African-specific locus for BMI (SEMA4D, rs80068415). A novel variant in SEMA4D was significantly associated with body mass index. Carriers of the C allele were 4.6 BMI units heavier than carriers of the T allele.

  2. A critical pathogenic engagement of Semaphorin 4D produced by gamma delta T cells in the development of medication-related osteonecrosis of the jaw

  3. Our results identified FGL2 (show FGL2 Antibodies), GAL (show GAL Antibodies), SEMA4D, SEMA7A (show SEMA7A Antibodies), and IDO1 (show IDO1 Antibodies) as new candidate genes that could be involved in MSCs-mediated immunomodulation. FGL2 (show FGL2 Antibodies), GAL (show GAL Antibodies), SEMA4D, SEMA7A (show SEMA7A Antibodies), and IDO1 (show IDO1 Antibodies) genes appeared to be differentially transcribed in the different MSC (show MSC Antibodies) populations. Moreover, these genes were not similarly modulated following MSCs-exposure to inflammatory signals

  4. Interferon-alpha (show IFNA Antibodies)-induced CD100 expression on naive CD8 (show CD8A Antibodies)(+) T cells enhances antiviral responses to hepatitis C infection through CD72 (show CD72 Antibodies) signal transduction.

  5. In this review, we summarized the current findings on neuroimmune Sema4A (show Sema4a Antibodies) and Sema4D molecules in chronic inflammation underlying many diseases and discussed their positive or negative impacts on the implicated molecular and cellular processes

  6. we have identified a novel reverse signaling pathway acting through Tiam1 (show TIAM1 Antibodies) and Rac (show AKT1 Antibodies) that promotes aggressive behavior in OSCC expressing S4D and PB1 (show SMR3A Antibodies).

  7. sema (show SEMA3B Antibodies) 4D was the direct target of miR (show MLXIP Antibodies)-214 and was negatively regulated by miR (show MLXIP Antibodies)-214 in ovarian cancer cells

  8. Tax (show CNTN2 Antibodies) and semaphorin 4D released from lymphocytes infected with human lymphotropic virus type 1 and inhibit neurite growth in a neuron cell line.

  9. This assay specifically and reproducibly measured cSEMA4D saturation and expression levels. Evaluation of the SEMA4D-specific PD markers were critical in determining the clinical saturation threshold of cSEMA4D by VX15/2503

  10. Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer.

Mouse (Murine) Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) and Short Cytoplasmic Domain, (Semaphorin) 4D (SEMA4D) interaction partners

  1. Absence of Sema4D improves oligodendrocyte recovery after cerebral ischemia/reperfusion injury in mice

  2. Sema4D-deficiency affected ischemia-induced microglial activation in morphology, iNOS (show NOS2 Antibodies) expression, and proliferation, and this deficiency most likely resulted in moderation of cytotoxicity and locomotor behavioral abnormality after cerebral ischemia

  3. The addition of recombinant Sema4D to Sema4D/ vaginal epithelial cells in culture significantly enhanced apoptosis of the vaginal epithelial cells.

  4. Sema4D may be an essential apoptosis-inducing ligand that acts downstream of estrogen action in vaginal epithelium during pubertal tissue remodeling.

  5. therapeutic effects via bone-targeting systems featuring interference of Sema4d are able to partly counteract alveolar bone loss caused by osteoporosis.

  6. CD100-mediated signals are critical for effective activation of gammadelta IEL to produce growth factors, including KGF (show FGF7 Antibodies)-1, that are required for healing of the colon epithelium during colitis.

  7. Deletion of plexin-B1 (show PLXNB1 Antibodies), the high affinity receptor for semaphorin 4D, significantly (one-way ANOVA; p < 0.001) reduced thrombus weight (- 40%) in oxidative venous thrombosis.

  8. Data indicate neuroimmune semaphorin 4D (Sema4D) as an important regulator of Th2-driven lung pathophysiology and as a potential target for a combinatory disease immunotherapy.

  9. Sema (show SEMA3B Antibodies) 4D/CD100 is not only a ligand for plexin B1 (show PLXNB1 Antibodies) but also a direct signaling receptor in mediating Sema (show SEMA3B Antibodies) 4D/CD100-plexin B's biological functions.

  10. CD100 deficiency in vivo resulted in delayed repair of cutaneous wounds due to a disrupted gamma-delta T cell response to keratinocyte damage.

SEMA4D Antigen Profile

Antigen Summary

Cell surface receptor for PLXN1B and PLXNB2 that plays an important role in cell-cell signaling. Promotes reorganization of the actin cytoskeleton and plays a role in axonal growth cone guidance in the developing central nervous system. Regulates dendrite and axon branching and morphogenesis. Promotes the migration of cerebellar granule cells and of endothelial cells. Plays a role in the immune system\; induces B-cells to aggregate and improves their viability (in vitro). Promotes signaling via SRC and PTK2B/PYK2, which then mediates activation of phosphatidylinositol 3-kinase and of the AKT1 signaling cascade. Interaction with PLXNB1 mediates activation of RHOA (By similarity).

Alternative names and synonyms associated with SEMA4D

  • sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D (Sema4d) antibody
  • sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D (SEMA4D) antibody
  • C9orf164 antibody
  • CD100 antibody
  • COLL-4 antibody
  • M-sema-G antibody
  • Semacl2 antibody
  • Semaj antibody
  • Semcl2 antibody

Protein level used designations for SEMA4D

semaphorin-4D , A8 , BB18 , GR3 , sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4D , M-sema G , sema J , semaphorin H , semaphorin-C-like 2 , semaphorin-J , semaphorin 4D , collapsin-4

GENE ID SPECIES
306790 Rattus norvegicus
100152598 Sus scrofa
785942 Bos taurus
10507 Homo sapiens
20354 Mus musculus
100346590 Oryctolagus cuniculus
100732888 Cavia porcellus
476350 Canis lupus familiaris
396331 Gallus gallus
Selected quality suppliers for anti-SEMA4D (SEMA4D) Antibodies
Did you look for something else?